Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.19 CAD | +0.73% |
|
-0.29% | +7.38% |
05-22 | Great-West Lifeco Appoints Lindsey Rix-Broom as CEO, Europe Effective July 1, 2025 | CI |
05-22 | Great-West Lifeco Appoints Lindsey Rix-Broom as CEO, Europe | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 0.42 | 0.37 | 0.41 | 0.65 | 0.77 | |||||
Return on Total Capital | 6.34 | 5.89 | 6.48 | 11.23 | 12.94 | |||||
Return On Equity % | 12 | 12.39 | 11.25 | 10.28 | 13.58 | |||||
Return on Common Equity | 14.26 | 13.66 | 12.68 | 12.1 | 15.75 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 16.11 | 16.99 | 27.57 | 44.76 | 48.58 | |||||
SG&A Margin | 9.05 | 9.93 | 15.9 | 20.49 | 20.29 | |||||
EBITDA Margin % | 6.48 | 6.46 | 10.81 | 24.34 | 28.26 | |||||
EBITA Margin % | 6.27 | 6.28 | 10.55 | 24.07 | 28.01 | |||||
EBIT Margin % | 5.87 | 5.75 | 9.72 | 22.89 | 26.81 | |||||
Income From Continuing Operations Margin % | 5.2 | 5.58 | 7.91 | 9.65 | 12.22 | |||||
Net Income Margin % | 5.07 | 5.11 | 7.49 | 9.18 | 11.72 | |||||
Net Avail. For Common Margin % | 4.85 | 4.9 | 7.2 | 9.16 | 11.55 | |||||
Normalized Net Income Margin | 3.25 | 2.8 | 5.1 | 6.52 | 8.88 | |||||
Levered Free Cash Flow Margin | -27.66 | 2.44 | -22.59 | -1.91 | -15.08 | |||||
Unlevered Free Cash Flow Margin | -27.39 | 2.75 | -22.07 | 5.76 | -7.55 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.12 | 0.1 | 0.07 | 0.05 | 0.05 | |||||
Fixed Assets Turnover | 37.31 | 40.52 | 29.4 | 21.79 | 24.64 | |||||
Receivables Turnover (Average Receivables) | 31 | 32.42 | 33.38 | 20.51 | 24.16 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 15.84 | 14.96 | 11.94 | 12.42 | 29.02 | |||||
Quick Ratio | 13.27 | 12.57 | 9.87 | 10.6 | 25.38 | |||||
Operating Cash Flow to Current Liabilities | 1 | 1.01 | 0.49 | 0.3 | 0.65 | |||||
Days Sales Outstanding (Average Receivables) | 11.81 | 11.26 | 10.93 | 17.8 | 15.15 | |||||
Average Days Payable Outstanding | 32.83 | 30.72 | 90.26 | 75.7 | 83.83 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 39.63 | 31.93 | 34.93 | 32.33 | 43.97 | |||||
Total Debt / Total Capital | 28.38 | 24.2 | 25.89 | 24.43 | 30.54 | |||||
LT Debt/Equity | 34.07 | 29.71 | 31.13 | 30.67 | 41.14 | |||||
Long-Term Debt / Total Capital | 24.4 | 22.52 | 23.07 | 23.17 | 28.57 | |||||
Total Liabilities / Total Assets | 95.5 | 95.17 | 95.39 | 95.81 | 95.93 | |||||
EBIT / Interest Expense | 13.35 | 11.73 | 11.77 | 1.87 | 2.23 | |||||
EBITDA / Interest Expense | 14.99 | 13.4 | 13.28 | 2 | 2.36 | |||||
(EBITDA - Capex) / Interest Expense | 14.99 | 13.4 | 13.28 | 2 | 2.36 | |||||
Total Debt / EBITDA | 2.67 | 2.32 | 2.3 | 1.26 | 1.45 | |||||
Net Debt / EBITDA | 0.82 | 1.18 | 1 | 0.34 | 0.49 | |||||
Total Debt / (EBITDA - Capex) | 2.67 | 2.32 | 2.3 | 1.26 | 1.45 | |||||
Net Debt / (EBITDA - Capex) | 0.82 | 1.18 | 1 | 0.34 | 0.49 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 35.7 | 5.21 | -30.63 | 2.8 | 11.19 | |||||
Gross Profit, 1 Yr. Growth % | 6.92 | 10.94 | 7.55 | 2.75 | 20.7 | |||||
EBITDA, 1 Yr. Growth % | 11.39 | 4.94 | 1.96 | -5.5 | 29.07 | |||||
EBITA, 1 Yr. Growth % | 11.69 | 5.37 | 2.08 | -5.35 | 29.41 | |||||
EBIT, 1 Yr. Growth % | 12.08 | 2.97 | 1.38 | -5.76 | 30.22 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 25.81 | 12.97 | -0.81 | -17.85 | 40.76 | |||||
Net Income, 1 Yr. Growth % | 23.43 | 6.05 | 2.67 | -23.03 | 41.91 | |||||
Normalized Net Income, 1 Yr. Growth % | 9.9 | -9.34 | 5.02 | -25.68 | 51.61 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 27.24 | 5.93 | 2.74 | -21.08 | 39.74 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -2.67 | -3.55 | -3.43 | -8.03 | 5.24 | |||||
Accounts Receivable, 1 Yr. Growth % | 19.1 | 14.22 | -11.78 | 4.65 | 0 | |||||
Total Assets, 1 Yr. Growth % | 33.1 | 5 | 11.26 | 6.1 | 12.47 | |||||
Common Equity, 1 Yr. Growth % | 6.77 | 14.93 | 7.32 | 4 | 11.22 | |||||
Tangible Book Value, 1 Yr. Growth % | -27.73 | 43.02 | -4.28 | 32.06 | 24.48 | |||||
Cash From Operations, 1 Yr. Growth % | 57.28 | 7.94 | -32.06 | 28 | -1.59 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 43.97 | -108.14 | -619.34 | -98.18 | -41.92 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 44.6 | -109.24 | -561.09 | -105.87 | -60.42 | |||||
Dividend Per Share, 1 Yr. Growth % | 6.05 | 2.97 | 8.65 | 6.12 | 6.73 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 17.42 | 19.48 | -14.16 | -30.37 | 6.91 | |||||
Gross Profit, 2 Yr. CAGR % | 1.66 | 8.91 | 12.28 | 10.47 | 11.36 | |||||
EBITDA, 2 Yr. CAGR % | -1.17 | 8.12 | 10.88 | 26.67 | 10.44 | |||||
EBITA, 2 Yr. CAGR % | -1.63 | 8.48 | 11.38 | 27.56 | 10.67 | |||||
EBIT, 2 Yr. CAGR % | -2.08 | 7.43 | 10.4 | 29.2 | 10.78 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 1.28 | 19.21 | 5.85 | -8.01 | 7.54 | |||||
Net Income, 2 Yr. CAGR % | -0.29 | 14.41 | 4.34 | -6.23 | 4.51 | |||||
Normalized Net Income, 2 Yr. CAGR % | -5.41 | -0.18 | 7.56 | -3.19 | 6.15 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 2.93 | 16.09 | 4.32 | -4.41 | 5.02 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.64 | -3.11 | -3.49 | -5.76 | -1.62 | |||||
Accounts Receivable, 2 Yr. CAGR % | 13.9 | 16.64 | 0.38 | -21.66 | 2.3 | |||||
Total Assets, 2 Yr. CAGR % | 18.49 | 18.21 | 8.08 | 6.36 | 9.24 | |||||
Common Equity, 2 Yr. CAGR % | -1.14 | 10.77 | 11.06 | -0.78 | 7.55 | |||||
Tangible Book Value, 2 Yr. CAGR % | -21.68 | 1.67 | 17 | -7.98 | 28.21 | |||||
Cash From Operations, 2 Yr. CAGR % | 21.65 | 30.3 | -14.37 | -31.78 | 12.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 127.87 | -63.42 | -27.4 | -44.62 | -59.99 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 122.41 | -60.91 | -27.92 | -8.33 | -70.75 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.11 | 4.5 | 5.77 | 7.38 | 6.43 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 8.79 | 13.2 | -0.01 | -19.85 | -18.62 | |||||
Gross Profit, 3 Yr. CAGR % | 3.46 | 4.66 | 10.47 | 12.68 | 13.78 | |||||
EBITDA, 3 Yr. CAGR % | 1.63 | 0.82 | 11.05 | 24.61 | 27.47 | |||||
EBITA, 3 Yr. CAGR % | 1.29 | 0.65 | 11.49 | 25.52 | 28.17 | |||||
EBIT, 3 Yr. CAGR % | 0.89 | -0.42 | 10.96 | 26.14 | 29.54 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 10.97 | 5.03 | 12.13 | -1.49 | 6 | |||||
Net Income, 3 Yr. CAGR % | 10.53 | 1.78 | 10.35 | -2.31 | 7.66 | |||||
Normalized Net Income, 3 Yr. CAGR % | 0.34 | -6.74 | 8.33 | 1.07 | 12.42 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 13.49 | 3.92 | 11.46 | -1.08 | 8.49 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 16.71 | 9.48 | -3.22 | -5.03 | -2.23 | |||||
Accounts Receivable, 3 Yr. CAGR % | 13.66 | 14 | 6.27 | -11.17 | -15.02 | |||||
Total Assets, 3 Yr. CAGR % | 12.67 | 13.81 | 15.85 | 5.9 | 8.36 | |||||
Common Equity, 3 Yr. CAGR % | 2.34 | 3.95 | 9.61 | 4.2 | 3.07 | |||||
Tangible Book Value, 3 Yr. CAGR % | -11.47 | -4.27 | -0.36 | 6.59 | 1.77 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.46 | 16.9 | 4.87 | -20.5 | -22.92 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 381.87 | -21.56 | -4.67 | -68.54 | 39.14 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 273.32 | -19.45 | -4.95 | -54.42 | 7.01 | |||||
Dividend Per Share, 3 Yr. CAGR % | 6.07 | 5.05 | 5.86 | 5.89 | 7.16 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 12.4 | 6.58 | -1.05 | -6.62 | -4.92 | |||||
Gross Profit, 5 Yr. CAGR % | 2.21 | 3.56 | 6.9 | 8.14 | 13.05 | |||||
EBITDA, 5 Yr. CAGR % | -0.52 | 0.73 | 5.23 | 13.57 | 22.71 | |||||
EBITA, 5 Yr. CAGR % | -0.79 | 0.57 | 5.21 | 13.86 | 23.37 | |||||
EBIT, 5 Yr. CAGR % | -1.32 | -0.25 | 4.59 | 13.99 | 23.98 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 0.93 | 3.81 | 8.89 | -0.39 | 11.1 | |||||
Net Income, 5 Yr. CAGR % | 1.27 | 3.37 | 8.01 | -1.51 | 10.31 | |||||
Normalized Net Income, 5 Yr. CAGR % | -0.95 | -1.65 | 3.17 | -1.58 | 11.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 2.76 | 4.76 | 9.73 | 0.5 | 11.47 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.02 | 10.17 | 8.17 | 3.11 | -2.58 | |||||
Accounts Receivable, 5 Yr. CAGR % | 19.34 | 10.76 | 8.15 | -1.88 | -3.55 | |||||
Total Assets, 5 Yr. CAGR % | 8.47 | 9.54 | 10.81 | 10.77 | 12.2 | |||||
Common Equity, 5 Yr. CAGR % | 1.36 | 4.68 | 5.74 | 2.03 | 6.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | -7.05 | 0.75 | -1.02 | -5.77 | 1.73 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.41 | 10.65 | 0.84 | -5.76 | -4.91 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 43.42 | 0.25 | 132.08 | -28.68 | -14.78 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 44.99 | 5.1 | 98.6 | -11.74 | -25.59 | |||||
Dividend Per Share, 5 Yr. CAGR % | 6.08 | 5.44 | 5.95 | 5.98 | 6.09 |
- Stock Market
- Equities
- GWO Stock
- Financials Great-West Lifeco Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition